Program
DW4421S
A development code. Also written as “DW4421S-T1”, “DW4421S-T0” and “DW4421S-T2”.
Its studies are led by Daewon Pharmaceutical.
Furthest: phase 1, since Jan 6, 20263 company-led studies, 3 open or runningNext primary completion: Dec 2026 (phase 1)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Daewon Pharmaceutical | 33 open or running | phase 1since Jan 6, 2026 | Jan 6, 2026 | Dec 2026phase 1 · NCT07691242 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 6, 2026First studies: 2 phase 1 studies in Healthy Adult VolunteerFirst studyNCT07364877, NCT07364851
- Jun 24, 2026Phase 1 study in Healthy Adult VolunteersNCT07691242 · 56 planned · South Korea
Ahead
- Dec 2026Primary completion: phase 1 study in Healthy Adult VolunteersNCT07691242
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07691242Healthy Adult Volunteers · South Korea | 1 | Not yet recruiting | Dec 2026 | 56 |
| NCT07364877Healthy Adult Volunteer · South Korea | 1 | By invitation | Mar 19, 2026 | 38 |
| NCT07364851Healthy Adult Volunteer · South Korea | 1 | Not yet recruiting | May 30, 2026 | 38 |
How it is read
Names in the registry
- “DW4421S-T1”, 2 entries
- “DW4421S”, 2 entries
- “DW4421S-T0”, 1 entry
- “DW4421S-T2”, 1 entry
- “DW4421S-T3”, 1 entry
Codes read as this program: DW4421S.
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.